Hyperlipidaemia and its risk factors in the Guangxi Bai Ku Yao and Han populations

Public Health Nutrition

Volumn 12, Issue 6, 2009, Pages 816-824

  Ruixing, Yin ^a   Dezhai, Yang ^a   Shuquan, Li ^a   Yuming, Chen ^a   Hanjun, Yang ^b   Qiming, Feng ^a   Shangling, Pan ^a   Weixiong, Lin ^a   Jing, Tan ^c   Yiyang, Li ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b Health Bureau of Nandan County   (China)

^c Department of Internal Medicine   (China)

Author keywords

Apolipoproteins; Hyperlipidaemia; Lipids; Prevalence; Risk factors

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CALORIC INTAKE; CHINA; CORRELATION ANALYSIS; DIETARY FIBER; FAT INTAKE; FEEDING BEHAVIOR; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; WAIST CIRCUMFERENCE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DIET; ETHNIC GROUP; ETHNOLOGY; HEALTH SURVEY; MIDDLE AGED; MINORITY GROUP; QUESTIONNAIRE; STANDARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHINA; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DIET; ETHNIC GROUPS; FEMALE; FOOD HABITS; HEALTH SURVEYS; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LIFE STYLE; MALE; MIDDLE AGED; MINORITY GROUPS; PREVALENCE; QUESTIONNAIRES; RISK FACTORS; YOUNG ADULT;

EID: 67650727089     PISSN: 13689800     EISSN: 14752727     Source Type: Journal    
DOI: 10.1017/S1368980008003273     Document Type: Article

References (53)

1. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr & Stone NJ; National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239.
2. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil 10, Suppl. 1, S1-S78.
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
4. Satoh H, Nishino T, Tomita K & Tsutsui H (2006) Fasting triglyceride is a significant risk factor for coronary artery disease in middle-aged Japanese men: results from a 10- year cohort study. Circ J 70, 227-231. (Pubitemid 43312240)
5. Achari V & Thakur AK (2004) Association of major modifiable risk factors among patients with coronary artery disease - a retrospective analysis. J Assoc Physicians India 52, 103-108. (Pubitemid 44194608)
6. Kwiterovich PO Jr, Coresh J, Smith HH, Bachorik PS, Derby CA & Pearson TA (1992) Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease. Am J Cardiol 69, 1015-1021. (Pubitemid 23058996)
7. Boden WE (2000) High-density lipoprotein cholesterol as an independent risk factor in cardiovascular disease: assessing the data from Framingham to the Veterans Affairs High-Density Lipoprotein Intervention Trail. Am J Cardiol 86, 19L-22L.
8. Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D & Patsch W, Atherosclerosis Risk in Communities Study Group (2001) Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104, 1108-1113. (Pubitemid 32830392)
9. Sociedade Brasileira de Cardiologia (2001) III Diretrizes Brasileiras Sobre Dislipidemias e Diretrizes de Prevenção da Aterosclerose. Arq Bras Cardiol 77, Suppl. III, 1-48.
10. Bermudez OI, Velez-Carrasco W, Schaefer EJ & Tucker KL (2002) Dietary and plasma lipid, lipoprotein, and apolipoprotein profiles among elderly Hispanics and non-Hispanics and their association with diabetes. Am J Clin Nutr 76, 1214-1221. (Pubitemid 35416554)
11. Srinivasan SR, Freedman DS, Webber LS & Berenson GS (1987) Black-white differences in cholesterol levels of serum high-density lipoprotein subclasses among children: the Bogalusa Heart Study. Circulation 76, 272-279. (Pubitemid 17124743)
12. Nethononda MR, Essop MR, Mbewu AD & Galpin JS (2004) Coronary artery disease and risk factors in Black South Africans - a comparative study. Ethn Dis 14, 515-519.
13. People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group (1992) An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People's Republic of China. Baseline report from the PRC-USA Collaborative Study. Circulation 85, 1083-1096.
14. Lyu LC, Yeh CY, Lichtenstein AH, Li Z, Ordovas JM & Schaefer EJ (2001) Association of sex, adiposity, and diet with HDL subclasses in middle-aged Chinese. Am J Clin Nutr 74, 64-71. (Pubitemid 32574912)
15. Yang YX, Wang GY & Pan XC (2002) The 2002 Chinese Food Composition Table. Beijing: Medical Publishing House of Beijing University.
16. Paffenbarger RS, Wing AL & Hyde RT (1978) Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 108, 161-175.
17. Yin R, Chen Y, Pan S et al. (2006) Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations. Arch Med Res 37, 787-793.
18. Yin R, Wang Y, Chen G, Lin W, Yang D & Pan S (2006) Lipoprotein lipase gene polymorphism at Pvu II locus and serum lipid levels in the Guangxi Hei Yi Zhuang and Han populations. Clin Chem Lab Med 44, 1416-1421. (Pubitemid 44967689)
19. Ruixing Y, Limei Y, Yuming C, Dezhai Y, Weixiong L, Muyan L, Fengping H, Jinzhen W, Guangqing Y & Zhenbiao N (2006) Prevalence, awareness, treatment, control and risk factors of hypertension in the Guangxi Hei Yi Zhuang and Han populations. Hypertens Res 29, 423-432.
20. Ruixing Y, Jiaqiang D, Dezhai Y, Weixiong L, Shangling P, Jinzhen W, Jiandong H & Xiuyan L (2006) Effects of demographic characteristics, health-related behaviors and lifestyle factors on the prevalence of hypertension for the middle-aged and elderly in the Guangxi Hei Yi Zhuang and Han populations. Kidney Blood Press Res 29, 312-320. (Pubitemid 46033018)
21. Cooperative Meta-analysis Group of China Obesity Task Force (2002) Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23, 5-10.
22. von Kamp A & Schuster S (2006) Metatool 5.0: fast and flexible elementary modes analysis. Bioinformatics 22, 1930-1931. (Pubitemid 44283044)
23. Dong W, Ma X, Zhang D & Yu S (2002) Effect of maize embryo on delaying aging. Food Sci 23, 95-97.
24. Jenkins DJ, Kendall CW, Axelsen M, Augustin LS & Vusksan V (2000) Viscous and nonviscous fibres, nonabsorbable and low glycaemic index carbohydrates, blood lipids and coronary heart disease. Curr Opin Lipidol 11, 49-56. (Pubitemid 30148198)
25. Lairon D (1996) Dietary fibres: effects on lipid metabolism and mechanisms of action. Eur J Clin Nutr 50, 125-133.
26. Liu Y, Zhang L & Wu Y (1995) The dietary therapy for hyperlipidemia complicated with NIDDM. Chin J Clin Nutr 3, 174-176.
27. Zhang Y, Zhou Y, Wu F & Zhang M (1996) The comparative effects of maize oil and lard on blood lipids serum glucose and brain lipofuscin in rats. Acta Nutrimenta Sinica 18, 274-279.
28. Anderson JW, Johnstone BM & Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333, 276-282.
29. Zhang HW, Zhang YH, Lu MJ, Tong WJ & Cao GW (2007) Comparison of hypertension, dyslipidaemia and hyperglycaemia between buckwheat seed-consuming and non-consuming Mongolian-Chinese populations in Inner Mongolia, China. Clin Exp Pharmacol Physiol 34, 838-844.
30. Ludvik BH, Mahdjoobian K, Waldhaeusl W, Hofer A, Prager R, Kautzky-Willer A & Pacini G (2002) The effect of Ipomoea batatas (caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care 25, 239-240.
31. Ludvik B, Neuffer B & Pacini G (2004) Efficacy of Ipomoea batatas (caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care 27, 436-440. (Pubitemid 38174068)
32. al-Zuhair H, Abd el-Fattah AA & Abd el Latif HA (1997) Efficacy of simvastatin and pumpkin-seed oil in the management of dietary-induced hypercholesterolemia. Pharmacol Res 35, 403-408.
33. Zhang Y & Wang ZZ (2006) GC-MS analysis of fat-soluble constituents of hemp kernels. Acta Bot Boreal Occident Sin 26, 1955-1958.
34. 9-THC content of both drug- and fiber-type cannabis seeds. J Anal Toxicol 24, 715-717.
35. Zhou YH (2004) Analysis of fatty acid in hemp fruit oil with GC-MS. Chin Oils Fats 29, 72-73.
36. Ren HY, Sun HG, Ma JZ, Zhang Y, Yi CR, Wu MX, Liu WL & Li GL (1997) Experimental study on the effects of hemp fruit oil on serum lipid levels and lipid peroxidation. Chin J Tradit Med Sci Technol 4, 200.
37. Ren HY, Sun HG, Zhang Y, Yi CR, Wu MX, Li GL & Liu WL (1998) Lipid-lowering and antiatherosclerotic effects of hemp fruit oil in partridges. Henan Tradit Chin Med 18, 294-295.
38. Schwab US, Callaway J, Erkkila AT, Gynther J, Uusitupa MI & Jarvinen T (2006) Effects of hempseed and flaxseed oils on the profile of serum lipids, serum total and lipoprotein lipid concentrations and haemostatic factors. Eur J Nutr 45, 470-477. (Pubitemid 46020598)
39. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S & Kris-Etherton P (1999) Effects of National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 69, 632-646. (Pubitemid 29193386)
40. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M & Golden SH, Atherosclerosis Risk in Communities Study (2005) Endogenous postmenopausal hormones and serum lipids: the Atherosclerosis Risk in Communities Study. J Clin Endocrinol Metab 90, 1202-1209.
41. Cheung AP (2000) Acute effects of estradiol and progesterone on insulin, lipids and lipoproteins in postmenopausal women: a pilot study. Maturitas 35, 45-50.
42. Karki DB, Neopane A, Pradhan B & Magar A (2004) Lipid levels in Nepalese population. Kathmandu Univ Med J (KUMJ) 2, 349-353.
43. Guize L, Benetos A, Thomas F, Malmejac A & Ducimetiere P (1998) Cholesterolemia and total, cardiovascular and cancer mortality. Study of a cohort of 220,000 people. Bull Acad Natl Med 182, 631-650.
44. Li D, Yu XM, Zhou XQ, Zhang YH, Yao T & Sinclair AJ (2004) Relationship between BMI and serum and lipoprotein lipids in the Hangzhou region. Asia Pac J Clin Nutr 13, S68.
45. Mataix J, Lopez-Frias M, Martinez-de-Victoria E, Lopez- Jurado M, Aranda P & Llopis J (2005) Factors associated with obesity in an adult Mediterranean population: influence on plasma lipid profile. J Am Coll Nutr 24, 456-465. (Pubitemid 43373170)
46. Kawada T (2002) Body mass index is a good predictor of hypertension and hyperlipidemia in a rural Japanese population. Int J Obes Relat Metab Disord 26, 725-729.
47. Houston MC, Basile J, Bestermann WH et al. (2005) Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States. Am J Med Sci 329, 276-291. (Pubitemid 40847696)
48. Pei D, Kuo SW, Wu DA, Lin TY, Hseih MC, Lee CH, Hsu WL, Chen SP, Sheu WH & Li JC (2005) The relationships between insulin resistance and components of metabolic syndrome in Taiwanese Asians. Int J Clin Pract 59, 1408-1416. (Pubitemid 43922627)
49. Catalano M, Aronica A, Carzaniga G, Seregni R & Libretti A (1991) Serum lipids and apolipoproteins in patients with essential hypertension. Atherosclerosis 87, 17-22.
50. Bonaa KH & Thelle DS (1991) Association between blood pressure and serum lipids in a population. The Tromso Study. Circulation 83, 1305-1314.
51. Li J, Niu Q, Li P, Wang S & Zhao S (1991) The levels of serum lipids, lipoprotein, and apolipoprotein in patients with essential hypertension. Chin J Cardiol 19, 317-319.
52. Borghi C, Dormi A, Veronesi M, Sangiorgi Z & Gaddi A; Brisighella Heart Study Working Party (2004) Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study. Am Heart J 148, 285-292. (Pubitemid 39092793)
53. Corella D, Tucker K, Lahoz C, Coltell O, Cupples LA, Wilson PW, Schaefer EJ & Ordovas JM (2001) Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study. Am J Clin Nutr 73, 736-745. (Pubitemid 32239228)